(Q53414964)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

Interleukin 2 increases protection against experimental rabies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

Perrin P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Leclerc C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Oth D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sureau P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Thibodeau L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 May 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

199-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus

21 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Interferon production in hamsters experimentally infected with rabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

[Role of interferon in rabies immunity]

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Interleukin 2: the molecule and its function

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Interleukin-2 augments natural killer cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Affinity-purified interleukin 2 induces proliferation of large but not small B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Structure and expression of a cloned cDNA for human interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Suppression of cell-mediated immunity by street rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Acute genital infection in guinea pigs: effect of recombinant interleukin-2 on herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2888%2980039-1

7 January 2021

10.1016/S0171-2985(88)80039-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3261273%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference